TreatmentNCT07420270
Study of The Effects of Mandibular Advancement Aligners in Treating Children With Class II Division 1 Malocclusion
A study testing Mandibular Advancement Aligner in people with Treatment and Growth Modification, run by University of Malaya at 1 site in Malaysia.
Trial summary
The goal of this clinical trial is to learn the effects of Mandibular Advancement Aligner in growth modification of children with Class II Division 1 malocclusion. It will also learn about the psychosocial impact of the participants during the process. Read more about this study
- Who is it for?
- Ages 11 to 16 years
- Conditions the study is for
- Treatment, Growth Modification
- What is being tested?
- Mandibular Advancement Aligner
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 21 participants
- Where
- 1 siteMalaysia
- Study dates
- 4 Jul 2024to 31 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 11 to 16 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Cervical Vertebrae Maturity: CS3-CS4 (Growing participants)
- Chronological age: 10-14 years old (Female), 12-16 years old (Male)
- Average or reduced lower anterior facial height (LAFH<57%)
- Mild to moderate skeletal Class II (4°<ANB<9°)
- Retrognathic mandible (SNB<78°)
- Increased overjet (7mm≤OJ≤11mm)
Show all 9Show fewer
- Increased overbite by more than 30%
- Molar relationship by more than ½ unit Class II bilaterally
- Mild to moderate crowding
Who cannot join
- Participant with an anterior open bite
- Participant with syndromic dentofacial anomalies
- Participant with a previous history of orthodontic intervention
- Participant with signs and symptoms of temporomandibular disorder
- Participant with severe facial asymmetry (Deviation ≥4mm)
- Not being consented to by both parents and participants
- Poor quality of pre-treatment Lateral Cephalometric records
- Participant with mental or physical disabilities affecting the ability to wear an appliance
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effects of Mandibular Advancement Aligners in Growth Modification of Class II Division 1 Malocclusion: A Randomised Controlled Trial
The goal of this clinical trial is to learn the effects of Mandibular Advancement Aligner in growth modification of children with Class II Division 1 malocclusion. It will also learn about the psychosocial impact of the participants during the process. The main questions it aims to answer are:
Is there a difference in the skeletal, dental and soft tissue effects of treatments using the mandibular advancement (MA) aligners?
Read more
What is the patient's perception on the treatment outcome and is there any difference between the group treated with the mandibular advancement (MA) aligners and the control group?
Is there any tooth movements can be assess during the treatments using the mandibular advancement (MA) aligners?
Participants will:
Participants will be randomly assigned to three groups: mandibular advancement (MA) aligners with vertical bite opening, mandibular advancement (MA) aligners without vertical bite opening, and twin-block appliances.
The intervention groups will receive specific instructions on how to wear the appliance accordingly.
The trial will span an estimated 6 months for each sample, during which monthly follow-up visits will be carried out to monitor the changes and compliance of the appliance.
The primary outcome measures include the measurements in the lateral cephalometric, changes in the intraoral assessment, and questionnaires.
- Conditions
- Treatment, Growth Modification
- Being tested
- Mandibular Advancement Aligner
- Keywords
- Class II Division 1 malocclusion, Mandibular advancement aligners, Twin Block appliance
- Medical subject headings
- Malocclusion, Angle Class II
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mandibular Advancement AlignerDevice
Device use as growth modification in children with Class II Division 1 malocclusion. The twin-block appliance have been used for a long time, whereas in recent years the aligner technology have come out with new design of the Mandibular Advancement Aligner.
| Study group | Role | What they receive |
|---|---|---|
| Mandibular Advancement Aligner with bite opening | Experimental | Active intervention, AngelAlign A6 system Receives: Device: Mandibular Advancement Aligner |
| Mandibular Advancement Aligner without bite opening | Experimental | Active intervention, Graphy system Receives: Device: Mandibular Advancement Aligner |
| Twin-block appliance | Experimental | Control group for the intervention Receives: Device: Mandibular Advancement Aligner |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change from Baseline in the skeletal, dentoalveolar, and soft tissue after 6 months as assessed by Lateral Cephalometric values
Comparing the value of linear and angular measurements of Lateral Cephalometric at baseline and after 6 months.
Measured: From enrollment to the end of treatment at 6 months
Secondary outcomes (1)
Changes from baseline in the participants' perceptions of oral health-related quality of life in Class II Division 1 malocclusion treatment at 6 months as assessed by the score of CPQ11-14 questionnaire.
The score of CPQ11-14 is as follows: "never" = 1, "hardly ever" = 2, "sometimes" = 3, "fairly often" = 4, and "very often" = 5.
Measured: From enrollment to the end of treatment at 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Feb 2026
- Study start4 Jul 2024
- Primary completion20 Oct 2025
- Study completion31 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (7)Papers the sponsor has linked to this study.
- Other trials for TreatmentStudies of the same condition, open and under way.
- More trials run by University of MalayaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants will be randomly assigned to three groups: mandibular advancement (MA) aligners with vertical bite opening, mandibular advancement (MA) aligners without vertical bite opening, and twin-block appliances (controlled group).
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 21 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Malaya
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Wey Mang Chek, Associate Prof, Study chair, Faculty of Dentistry, Universiti MalayaNurul Aliaa Ahmad Fauzi, Dr, Study director, Faculty of Dentistry, Universiti Malaya
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07420270
- Sponsor's protocol ID
- DF CD 2421/0057 (P)
- Status last verified
- Jul 2024
- First submitted
- 11 Jan 2026
- Last updated
- 19 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Access to participant information was restricted to research team members directly involved in data collection, analysis, and management. Furthermore, any published or disseminated findings were presented in aggregate form to prevent the identification of individual participants. Before the data collection, participants were informed about the confidentiality measures in place and were required to provide informed consent for their participation, including the use and storage of their data. Compliance with data protection regulations and ethical guidelines was ensured throughout the study to safeguard the confidentiality and privacy of the participants.
Publications
Salek, F., Benyahia, H., & Zaoui, F. (2025). Comparative efficacy of mandibular advancement aligners and conventional orthopedic appliances in treating Class II malocclusion: A systematic review. Discover Medicine, 2.
O'Brien K, Wright J, Conboy F, Sanjie Y, Mandall N, Chadwick S, Connolly I, Cook P, Birnie D, Hammond M, Harradine N, Lewis D, McDade C, Mitchell L, Murray A, O'Neill J, Read M, Robinson S, Roberts-Harry D, Sandler J, Shaw I. Effectiveness of early orthodontic treatment with the Twin-block appliance: a multicenter, randomized, controlled trial. Part 1: Dental and skeletal effects. Am J Orthod Dentofacial Orthop. 2003 Sep;124(3):234-43; quiz 339. doi: 10.1016/S0889540603003524.
PubMed 12970656Hosseini HR, Ngan P, Tai SK, Andrews LJ 2nd, Xiang J. A comparison of skeletal and dental changes in patients with a Class II relationship treated with clear aligner mandibular advancement and Herbst appliance followed by comprehensive orthodontic treatment. Am J Orthod Dentofacial Orthop. 2024 Feb;165(2):205-219. doi: 10.1016/j.ajodo.2023.08.015. Epub 2023 Oct 10.
PubMed 37831020He J, Hu L, Yuan Y, Wang P, Zheng F, Jiang H, Li W. Comparison between clear aligners and twin-block in treating class II malocclusion in children: a retrospective study. J Clin Pediatr Dent. 2024 Sep;48(5):125-130. doi: 10.22514/jocpd.2023.070. Epub 2024 Sep 3.
PubMed 39275829Al Subaie H, Alturki G, Alsulaimani F, Ghoneim S, Baeshen H. Assessment of dental, skeletal, and soft tissue changes following mandibular advancement with Invisalign in skeletal Class II. Saudi Dent J. 2024 Jan;36(1):66-71. doi: 10.1016/j.sdentj.2023.09.005. Epub 2023 Sep 14.
PubMed 38375387Ghorbani M, Mousavi SA, Bardideh E, Saeedi P, Shahnaseri S, Shafaee H, Akyalcin S. The Effectiveness of Functional Clear Aligners for Class II Correction in Growing Patients: A Systematic Review and Meta-Analysis. Orthod Craniofac Res. 2025 Aug;28(4):577-592. doi: 10.1111/ocr.12908. Epub 2025 Feb 26.
PubMed 40008555Caruso S, Nota A, Caruso S, Severino M, Gatto R, Meuli S, Mattei A, Tecco S. Mandibular advancement with clear aligners in the treatment of skeletal Class II. A retrospective controlled study. Eur J Paediatr Dent. 2021;22(1):26-30. doi: 10.23804/ejpd.2021.22.01.05.
PubMed 33719479
Study at a glance
From the registry record, last updated by the sponsor on 19 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Mandibular Advancement Aligners in Growth Modification of Class II Division 1 Malocclusion: A Randomised Controlled Trial
- ClinicalTrials.gov ID
- NCT07420270
- Acronym / sponsor ID
- DF CD 2421/0057 (P)
- Conditions
- Treatment, Growth Modification
- Keywords
- Class II Division 1 malocclusion, Mandibular advancement aligners, Twin Block appliance
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 21 participants (actual)
- Lead sponsor
- University of MalayaUniversity, hospital or other
- Study start
- 4 Jul 2024 (actual)
- Primary completion
- 20 Oct 2025 (actual)
- Study completion
- 31 Dec 2025 (actual)
- First posted
- 19 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn the effects of Mandibular Advancement Aligner in growth modification of children with Class II Division 1 malocclusion. It will also learn about the psychosocial impact of the participants during the process. The main questions it aims to answer are:
Is there a difference in the skeletal, dental and soft tissue effects of treatments using the mandibular advancement (MA) aligners?
What is the patient's perception on the treatment outcome and is there any difference between the group treated with the mandibular advancement (MA) aligners and the control group?
Is there any tooth movements can be assess during the treatments using the mandibular advancement (MA) aligners?
Participants will:
Participants will be randomly assigned to three groups: mandibular advancement (MA) aligners with vertical bite opening, mandibular advancement (MA) aligners without vertical bite opening, and twin-block appliances.
The intervention groups will receive specific instructions on how to wear the appliance accordingly.
The trial will span an estimated 6 months for each sample, during which monthly follow-up visits will be carried out to monitor the changes and compliance of the appliance.
The primary outcome measures include the measurements in the lateral cephalometric, changes in the intraoral assessment, and questionnaires.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 3
- Model description
- Participants will be randomly assigned to three groups: mandibular advancement (MA) aligners with vertical bite opening, mandibular advancement (MA) aligners without vertical bite opening, and twin-block appliances (controlled group).
| Arm | Type | Receives |
|---|---|---|
| Mandibular Advancement Aligner with bite opening | Experimental | Device: Mandibular Advancement AlignerActive intervention, AngelAlign A6 system |
| Mandibular Advancement Aligner without bite opening | Experimental | Device: Mandibular Advancement AlignerActive intervention, Graphy system |
| Twin-block appliance | Experimental | Device: Mandibular Advancement AlignerControl group for the intervention |
Who may qualify
- Ages
- 11 to 16 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (9 listed)
- Cervical Vertebrae Maturity: CS3-CS4 (Growing participants)
- Chronological age: 10-14 years old (Female), 12-16 years old (Male)
- Average or reduced lower anterior facial height (LAFH<57%)
- Mild to moderate skeletal Class II (4°<ANB<9°)
- Retrognathic mandible (SNB<78°)
Key exclusion criteria (8 listed)
- Participant with an anterior open bite
- Participant with syndromic dentofacial anomalies
- Participant with a previous history of orthodontic intervention
- Participant with signs and symptoms of temporomandibular disorder
- Participant with severe facial asymmetry (Deviation ≥4mm)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mandibular Advancement AlignerDevice use as growth modification in children with Class II Division 1 malocclusion. The twin-block appliance have been used for a long time, whereas in recent years the aligner technology have come out with new design of the Mandibular Advancement Aligner. | Device | Mandibular Advancement Aligner with bite opening, Mandibular Advancement Aligner without bite opening, Twin-block appliance |
Primary outcome
Change from Baseline in the skeletal, dentoalveolar, and soft tissue after 6 months as assessed by Lateral Cephalometric values
Time frame: From enrollment to the end of treatment at 6 months
Comparing the value of linear and angular measurements of Lateral Cephalometric at baseline and after 6 months.
1 secondary outcome
Changes from baseline in the participants' perceptions of oral health-related quality of life in Class II Division 1 malocclusion treatment at 6 months as assessed by the score of CPQ11-14 questionnaire.
Time frame: From enrollment to the end of treatment at 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Feb 2026.
- BackgroundSalek, F., Benyahia, H., & Zaoui, F. (2025). Comparative efficacy of mandibular advancement aligners and conventional orthopedic appliances in treating Class II malocclusion: A systematic review. Discover Medicine, 2.
- Background: PubMed 12970656O'Brien K, Wright J, Conboy F, Sanjie Y, Mandall N, Chadwick S, Connolly I, Cook P, Birnie D, Hammond M, Harradine N, Lewis D, McDade C, Mitchell L, Murray A, O'Neill J, Read M, Robinson S, Roberts-Harry D, Sandler J, Shaw I. Effectiveness of early orthodontic treatment with the Twin-block appliance: a multicenter, randomized, controlled trial. Part 1: Dental and skeletal effects. Am J Orthod Dentofacial Orthop. 2003 Sep;124(3):234-43; quiz 339. doi: 10.1016/S0889540603003524.
- Background: PubMed 37831020Hosseini HR, Ngan P, Tai SK, Andrews LJ 2nd, Xiang J. A comparison of skeletal and dental changes in patients with a Class II relationship treated with clear aligner mandibular advancement and Herbst appliance followed by comprehensive orthodontic treatment. Am J Orthod Dentofacial Orthop. 2024 Feb;165(2):205-219. doi: 10.1016/j.ajodo.2023.08.015. Epub 2023 Oct 10.
- Background: PubMed 39275829He J, Hu L, Yuan Y, Wang P, Zheng F, Jiang H, Li W. Comparison between clear aligners and twin-block in treating class II malocclusion in children: a retrospective study. J Clin Pediatr Dent. 2024 Sep;48(5):125-130. doi: 10.22514/jocpd.2023.070. Epub 2024 Sep 3.
- Background: PubMed 38375387Al Subaie H, Alturki G, Alsulaimani F, Ghoneim S, Baeshen H. Assessment of dental, skeletal, and soft tissue changes following mandibular advancement with Invisalign in skeletal Class II. Saudi Dent J. 2024 Jan;36(1):66-71. doi: 10.1016/j.sdentj.2023.09.005. Epub 2023 Sep 14.
- Background: PubMed 40008555Ghorbani M, Mousavi SA, Bardideh E, Saeedi P, Shahnaseri S, Shafaee H, Akyalcin S. The Effectiveness of Functional Clear Aligners for Class II Correction in Growing Patients: A Systematic Review and Meta-Analysis. Orthod Craniofac Res. 2025 Aug;28(4):577-592. doi: 10.1111/ocr.12908. Epub 2025 Feb 26.
- Background: PubMed 33719479Caruso S, Nota A, Caruso S, Severino M, Gatto R, Meuli S, Mattei A, Tecco S. Mandibular advancement with clear aligners in the treatment of skeletal Class II. A retrospective controlled study. Eur J Paediatr Dent. 2021;22(1):26-30. doi: 10.23804/ejpd.2021.22.01.05.
- Individual participant dataSharing planned: No. Access to participant information was restricted to research team members directly involved in data collection, analysis, and management. Furthermore, any published or disseminated findings were presented in aggregate form to prevent the identification of individual participants. Before the data collection, participants were informed about the confidentiality measures in place and were required to provide informed consent for their participation, including the use and storage of their data. Compliance with data protection regulations and ethical guidelines was ensured throughout the study to safeguard the confidentiality and privacy of the participants.
Related trials for Treatment
Not yet recruitingPhase 2
Extension Study of Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis (CDDY391A12201-extension)
Moderate to Severe Psoriatic Arthritis
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Enrolling by invitationPhase 2
A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer
Pancreatic Cancer Metastatic
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Wey Mang Chek, Associate Prof study chair
Faculty of Dentistry, Universiti Malaya
Nurul Aliaa Ahmad Fauzi, Dr study director
Faculty of Dentistry, Universiti Malaya
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Mandibular Advancement Aligner in people with Treatment and Growth Modification, run by University of Malaya at 1 site in Malaysia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Malaysia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change from Baseline in the skeletal, dentoalveolar, and soft tissue after 6 months as assessed by Lateral Cephalometric values (time frame: From enrollment to the end of treatment at 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07420270, which also lists 7 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Feb 2026.